Search Results - "Chainitikun, Sudpreeda"

Update on systemic treatment for newly diagnosed inflammatory breast cancer by Chainitikun, Sudpreeda, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.

“…[Display omitted] Inflammatory breast cancer (IBC) is a rare and aggressive disease, accounting for 2–4% of new cases of breast cancer. Owing to its aggressive…”
Get full text

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review by Chainitikun, Sudpreeda, Espinosa Fernandez, Jose Rodrigo, Long, James P, Iwase, Toshiaki, Kida, Kumiko, Wang, Xiaoping, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T

“…The current use of targeted therapy plus neoadjuvant chemotherapy for inflammatory breast cancer (IBC) is based on data extrapolated from studies in non-IBC…”
Get full text

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer by Chainitikun, Sudpreeda, Long, James P., Rodriguez-Bautista, Ruben, Iwase, Toshiaki, Tripathy, Debu, Fujii, Takeo, Ueno, Naoto T.

“…Purpose Combinations of endocrine therapy (ET) and targeted therapy (CDK4/6 or mTOR inhibitors) are standard of care for HR+/HER2− metastatic breast cancer…”
Get full text

What is the best systemic treatment for newly diagnosed inflammatory breast cancer?-a narrative review by Chainitikun, Sudpreeda, Mingmalairak, Siyamol, Parinyanitikul, Napa

“…The propose of this review to discuss of the systemic treatment options for newly diagnosed inflammatory breast cancer (IBC) including the recent data of…”
Get full text

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2- negative (HER2-) metastatic breast cancer (MBC) by Chainitikun, Sudpreeda, Long, James, Rodriguez-Bautista, Ruben, Iwase, Toshiaki, Tripathy, Debu, Fujii, Takeo, Ueno, Naoto T.

“…Abstract only 1056 Background: Combinations of endocrine therapy (ET) and targeted therapy (CDK4/6 or mTOR inhibitors) are standard of care for HR+/HER2- MBC…”
Get full text

Targeting Signaling Pathways in Inflammatory Breast Cancer by Wang, Xiaoping, Semba, Takashi, Phi, Lan Thi Hanh, Chainitikun, Sudpreeda, Iwase, Toshiaki, Lim, Bora, Ueno, Naoto T

“…Inflammatory breast cancer (IBC), although rare, is the most aggressive type of breast cancer. Only 2-4% of breast cancer cases are classified as IBC,…”
Get full text

Abstract PS2-23: Prospective study of circulating cancer-associated macrophage-like cells (CAMLs) in obese patients with advanced breast cancer by Iwase, Toshiaki, Parikh, Aaroh, Sahin, Onur, Raghavendra, Akshara S, Sapon, Maryanne E, James, Anjali, Shrimanker, Tushaar V, Chainitikun, Sudpreeda, Kida, Kumiko, Adams, Daniel L, Tang, Cha-Mei, Medrano, Andrea YD, Klopp, Ann H, Ueno, Naoto T

“…Abstract Background Cancer-associated macrophage-like cells (CAMLs) are rare circulating gigantic atypical cells exclusively found in the peripheral blood of…”
Get full text

Abstract P5-06-10: Validation of prognostic stage and anatomic stage in the American joint committee on cancer 8th edition for inflammatory breast cancer by Kida, Kumiko, Hess, Kenneth R, Lim, Bora, Iwase, Toshiaki, Chainitikun, Sudpreeda, Sapon, Maryanne E, Valero, Vicente, Lucci, Anthony, Le-Petross, Carisa, Woodward, Wendy A, Krishnamurthy, Savitri, Hortobagyi, Gabriel N, Tripathy, Debu, Ueno, Naoto T

“…Abstract Background: The American Joint Committee on Cancer (AJCC) recently updated its breast cancer staging system to incorporate biological factors,…”
Get full text

Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy by Iwase, Toshiaki, Parikh, Aaroh, Wenli, Dong, Shen, Yu, Adams, Daniel L, Tang, Cha-Mei, Cohen, Evan N, Reuben, James M, Shrimanker, Tushaar Vishal, Chainitikun, Sudpreeda, Kida, Kumiko, Raghavendra, Akshara Singareeka, Sapon, Maryanne E, Sahin, Onur, James, Anjali, Sridhar, Nithya, Klopp, Ann H, Tripathy, Debasish, Ueno, Naoto T

“…Cancer-associated macrophage-like cells (CAMLs) are rare, gigantic, and atypical circulating cells found exclusively in the peripheral blood of patients with…”
Get full text

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy by Iwase, Toshiaki, Parikh, Aaroh, Dibaj, Seyedeh S, Shen, Yu, Shrimanker, Tushaar Vishal, Chainitikun, Sudpreeda, Kida, Kumiko, Sapon, Maryanne E, Sahin, Onur, James, Anjali, Medrano, Andrea Yizel Delgado, Klopp, Ann H, Ueno, Naoto T

“…Our previous study indicated that a high amount of visceral adipose tissue was associated with poor survival outcomes in patients with early breast cancer who…”
Get full text

Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy by Costelloe, Colleen M., Lin, Patrick P., Chuang, Hubert H., Amini, Behrang, Chainitikun, Sudpreeda, Yu, Tse-Kuan, Ueno, Naoto T., Murphy, William A., Madewell, John E.

“…The mechanisms by which tumors metastasize to bone are complex. Upon the successful establishment of metastatic deposits in the skeleton, detection of the…”
Get full text

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer by Kida, Kumiko, Hess, Kenneth R., Lim, Bora, Iwase, Toshiaki, Chainitikun, Sudpreeda, Valero, Vicente, Lucci, Anthony, Le-Petross, Huong Carisa, Woodward, Wendy A., Krishnamurthy, Savitri, Hortobagyi, Gabriel N., Tripathy, Debu, Ueno, Naoto T.

“…The AJCC updated its breast cancer staging system to incorporate biological factors in the “prognostic stage”. We undertook this study to validate the…”
Get full text

Chapter 34 - Bone Metastases by Costelloe, Colleen M., Lin, Patrick P., Chuang, Hubert H., Amini, Behrang, Ueno, Naoto T., Chainitikun, Sudpreeda, Kuan, T., Madewell, John E.

“…Bone metastases are common and can profoundly influence the quality of life of cancer patients. Early and accurate detection is important for therapeutic…”
Get full text